Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Which Offers More Control: Index Fund Or Target Date Retirement. Understand where you have more say over allocations and timing for retirement planning.
28,368 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
A small BTC sale by Strategy is not a capitulation. The firm says the move funds preferred stock distributions while ...
SpaceX is exploring an IPO designed for everyday investors, outlining a plan to list shares and fund its space infras...
A longtime bitcoin advocate says MicroStrategy is a leveraged proxy for Bitcoin, and could trade at $1,000 per share ...
Box and DocuSign sit at different corners of the SaaS world. This analysis shows how quarterly revenue patterns illum...
Oil markets are in flux, and Occidental faces a pivotal year. This guide breaks down what to expect from occidental (...
The Supreme Court ruling blocks state-law cancer claims against Bayer tied to Roundup, a decision that reshapes litig...
A hypothetical $1,000 XRP bet on election night would have endured wild swings and sharp turns. Here’s the latest rea...
Analysts warn that the CLARITY Act's odds of passing have fallen below 50% as the Senate's August recess approaches. ...
A high-stakes clash between Ray Dalio and Michael Saylor drives a renewed bitcoin price analysis as markets digest Bi...
Sen. Ron Wyden is pushing Senate leadership to retain protections for blockchain developers in a sweeping crypto bill...
Trump Mobile says the gold-plated T1 phone will ship this week after nearly year delays, with deposits collected and ...